Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Breast pericytes: a newly identified driver of tumor cell proliferation.

Frontiers in oncology·2025

Same author

Comprehensive identification, isolation, and culture of human breast cell types.

The Journal of biological chemistry·2024

Same author

Ulcerative Colitis: Novel Epithelial Insights Provided by Single Cell RNA Sequencing.

Frontiers in medicine·2022

Same author

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.

Nature communications·2019

Same author

Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells.

The Journal of cell biology·2018

Same author

Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2016

Search research articles

Related Experiment Video

Updated: Aug 13, 2025

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Lost in transduction: Critical considerations when using viral vectors.

William C Hines¹, William C Hines²

¹Sandia National Laboratory, Albuquerque, NM, United States.

Frontiers in Cell and Developmental Biology

|January 23, 2023

Summary

This study explains how cell type differences affect retroviral vector transduction efficiency. It proposes an alternative to the multiplicity of infection (MOI) method for more accurate viral vector titration.

Keywords:

cell barcoding lentiviral vectors multiplicity of infection (MOI)scientific reproducibility viral transduction

More Related Videos

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

Related Experiment Videos

Last Updated: Aug 13, 2025

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

Area of Science:

Molecular Biology
Biotechnology
Gene Therapy

Background:

Retroviral vectors are essential tools in biomedical research for gene delivery.
Accurate titration of viral vectors is crucial for reproducible experimental results.
The multiplicity of infection (MOI) is a commonly used but potentially flawed method for quantifying viral vector preparations.

Purpose of the Study:

To elucidate the relationship between retroviral vector transduction efficiency and viral insertions per cell.
To highlight how differential cell-type susceptibility to transduction can complicate experimental outcomes.
To introduce and advocate for an alternative method to the standard MOI approach for viral vector titration.

Main Methods:

Mathematical modeling to describe the relationship between transduction efficiency and viral insertions.
Analysis of differential cell-type susceptibility in retroviral vector transduction.
Review and comparison of the traditional MOI method with an alternative titration strategy.

Main Results:

Observed transduction efficiency is directly influenced by the number of viral insertions per cell.
Variations in cell-type susceptibility can lead to inaccurate interpretations of transduction rates.
The proposed alternative method offers a more precise approach to viral vector quantification compared to MOI.

Conclusions:

Understanding per-cell viral insertions and cell-type specific transduction is critical for accurate retroviral vector applications.
The multiplicity of infection (MOI) method may not adequately account for biological variability in transduction.
Adopting alternative titration methods can enhance the reliability and reproducibility of experiments using retroviral vectors.